NSAID Carprofen Structure-based Derivatives as potential antibacterial agents

Authors

  • Nitin Kumar Institute of Pharmacy, Ram-Eesh institute of Vocational and Technical Education, Knowledge Park I, Greater Noida, INDIA
  • Pallavi Manish Lavhale Institute of Pharmacy, Ram-Eesh institute of Vocational and Technical Education, Knowledge Park I, Greater Noida, INDIA

DOI:

https://doi.org/10.22270/ajprd.v12i5.1478

Abstract

Drug repurposing (DR) is the use of existing drug in new alternative therapeutic role. Antibacterial perspective of non-antibiotic drugs includes NSAIDS are very useful to combat in a variety of infections in clinical practice. Carprofen (2-(6-chloro-9H-carbazol-2-yl)propanoic acid), is a NSAIDS category drug based on potential pharmacophore tricyclic carbazole nucleus, now commonly used in veterinary medicine. This carprofen drug is used in osteoarthritis and postoperative pain in dogs. Around the worldwide, researchers’ significantly revealed drug repurposing role of carprofen structure-based derivatives as antibacterial agents. These carprofen structure-based compounds displayed excellent antibacterial activities against gram positive as well as gram-negative bacterial strains in review literature. Some carprofen derivatives also displayed potential antibiofilm activity. Multi-target direct ligand (MTDLs) strategy also used to design novel carprofen integrated molecules tethered with potential bioactive pharmacophore like coumarin, 1,3,4-oxadiazole, hydrazide etc. also showed significant in vitro antibacterial activities. Articles related to carprofen as antibacterial agents collected on PubMed, Science direct and Google scholar mainly. However, less research works done on this topic. This review highlighted antibacterial potential of new carprofen derivatives based on carbazole structure tested against bacterial strains with their target mechanism based on literature.

 

Downloads

Download data is not yet available.

Author Biographies

Nitin Kumar, Institute of Pharmacy, Ram-Eesh institute of Vocational and Technical Education, Knowledge Park I, Greater Noida, INDIA

Institute of Pharmacy, Ram-Eesh institute of Vocational and Technical Education, Knowledge Park I, Greater Noida, INDIA

Pallavi Manish Lavhale, Institute of Pharmacy, Ram-Eesh institute of Vocational and Technical Education, Knowledge Park I, Greater Noida, INDIA

Institute of Pharmacy, Ram-Eesh institute of Vocational and Technical Education, Knowledge Park I, Greater Noida, INDIA

References

Rudrapal M, Khairnar SJ, Jadhav AG. Drug repurposing (DR): an emerging approach in drug discovery. Drug repurposing-hypothesis, molecular aspects and therapeutic applications. 2020 Jul 13;10.

Almeida HM, Brandão LB, de Melo TR, Ferreira SB. Anti-Bacterial Perspective of Non-Antibiotic Drugs. In Medical Sciences Forum 2022 Jun 15 (Vol. 12, No. 1, p. 22). MDPI.

Jourdan JP, Bureau R, Rochais C, Dallemagne P. Drug repositioning: a brief overview. Journal of Pharmacy and Pharmacology. 2020 Sep;72(9):1145-51.

Punekar M, Kshirsagar M, Tellapragada C, Patil K. Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system. Microbial Pathogenesis. 2022 Jul 1;168:105608.

Pancu DF, Scurtu A, Macasoi IG, Marti D, Mioc M, Soica C, Coricovac D, Horhat D, Poenaru M, Dehelean C. Antibiotics: conventional therapy and natural compounds with antibacterial activity—a pharmaco-toxicological screening. Antibiotics. 2021 Apr 7;10(4):401.

Kumar Nitin, Sharma Shalini, Agrawal Saurabh, Verma Vishesh, Antibacterial Potential of Tetrahydrocarbazoles (THCZ): A Review, Current Bioactive Compounds; Volume 20, Issue 10, Year 2024,

Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS microbiology. 2018;4(3):482.

Zhang F, Cheng W. The mechanism of bacterial resistance and potential bacteriostatic strategies. Antibiotics. 2022 Sep 8;11(9):1215.

Roope LS, Smith RD, Pouwels KB, Buchanan J, Abel L, Eibich P, Butler CC, Tan PS, Walker AS, Robotham JV, Wordsworth S. The challenge of antimicrobial resistance: what economics can contribute. Science. 2019 Apr 5;364(6435):eaau4679.

World Health Organization. 2021 antibacterial agents in clinical and preclinical development: an overview and analysis.

Petchiappan A, Chatterji D. Antibiotic resistance: current perspectives. ACS omega. 2017 Oct 31;2(10):7400-9.

Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nature reviews microbiology. 2015 Jan;13(1):42-51.

Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial antibiotic resistance: The most critical pathogens. Pathogens. 2021 Oct 12;10(10):1310.

Nikaido H. Multidrug resistance in bacteria. Annual review of biochemistry. 2009 Jul 7;78:119-46.

Foletto VS, da Rosa TF, Serafin MB, Bottega A, Hörner R. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: A systematic review. International Journal of Antimicrobial Agents. 2021 Sep 1;58(3):106380.

Paes Leme RC, da Silva RB. Antimicrobial activity of non-steroidal anti-inflammatory drugs on biofilm: Current evidence and potential for drug repurposing. Frontiers in microbiology. 2021 Jul 27;12:707629.

Yimer EM, Mohammed OA, Mohammedseid SI. Pharmacological exploitation of non-steroidal anti-inflammatory drugs as potential sources of novel antibacterial agents. Anti-Infective Agents. 2019 Aug 1;17(2):81-92.

Rumynska TM, Hural AR, Konechnyi YT, Vynnytska RB, Lozynskyi AV, Salyha YT, Korniychuk OP, Lesyk RB. Microbial biofilms and some aspects of anti-inflammatory drug use. Biopolymers & Cell. 2021;37(4):247.

Leão C, Borges A, Simões M. NSAIDs as a drug repurposing strategy for biofilm control. Antibiotics. 2020 Sep 10;9(9):591.

Shineh G, Mobaraki M, Perves Bappy MJ, Mills DK. Biofilm formation, and related impacts on healthcare, food processing and packaging, industrial manufacturing, marine industries, and sanitation–A review. Applied Microbiology. 2023 Jun 26;3(3):629-65.

Bordei AT, Limban C, Nuta DC, Zarafu IR, Denes M, Marutescu L, Chifiriuc MC, Popa M, Arama C. Recent advances in the study of derivatives of (EZ)-N’-benzylidene-(2RS)-2-(6-chloro-9h-carbazol-2-yl) propanohydrazide. Farmacia. 2022 Jul 1;70(4).

Dziedzic A, Kubina R, Wojtyczka RD, Kabała-Dzik A, Tanasiewicz M, Morawiec T. The antibacterial effect of ethanol extract of polish propolis on mutans streptococci and lactobacilli isolated from saliva. Evidence‐Based Complementary and Alternative Medicine. 2013;2013(1):681891.

Sahoo A, Swain SS, Behera A, Sahoo G, Mahapatra PK, Panda SK. Antimicrobial peptides derived from insects offer a novel therapeutic option to combat biofilm: A review. Frontiers in microbiology. 2021 Jun 10;12:661195.

Chan EW, Yee ZY, Raja I, Yap JK. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus. Journal of global antimicrobial resistance. 2017 Sep 1;10:70-4.

Vogler GA. Anesthesia and analgesia. In The laboratory rat 2006 Jan 1 (pp. 627-664). Academic Press.

Flecknell P. Laboratory animal anaesthesia. Academic press; 2015 Sep 21.

Nolan A, Reid J. Comparison of the postoperative analgesic and sedative effects of carprofen and papaveretum in the dog. The Veterinary Record. 1993 Sep 1;133(10):240-2.

Hanson PD, Maddison JE. Nonsteroidal anti-inflammatory drugs and chondroprotective agents. Small Animal Clinical Pharmacology. 2008;5:287.

Fox SM, Johnston SA. Use of carprofen for the treatment of pain and inflammation in dogs. Journal of the American Veterinary Medical Association. 1997 May 1;210(10):1493-8.

Bruni G, Maietta M, Berbenni V, Bini M, Ferrari S, Capsoni D, Boiocchi M, Milanese C, Marini A. Preparation and characterization of carprofen co-crystals. CrystEngComm. 2012;14(2):435-45.

Moreau M, Dupuis J, Bonneau NH, Desnoyers M. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Veterinary Record. 2003 Mar;152(11):323-9.

Kumar N, Kumar R, Nemaysh V, Lal N, Luthra PM. Bis ((1, 4-dimethyl-9 H-carbazol-3-yl) methyl) amine-mediated anticancer effect triggered by sequence-specific cleavage of DNA leading to programmed cell death in the human U87 cell line. RSC advances. 2016;6(72):67925-40.

Kumar N, Gupta P, Bansal S. Progress and development of carbazole scaffold based as potential anti-alzheimer agents using MTDL approach. Letters in Drug Design & Discovery. 2022 Dec 1;19(12):1049-67.

Kumar N, Nemaysh V, Luthra PM. Synthesis and anticancer activity evaluation of substituted carbazole bearing thiosemicarbazide derivatives against human glioma U87 MG cell line. World Journal of Advanced Research and Reviews. 2022;16(3):884-92.

Kumar N, Sharma S, Nirmal P. A Review of In Vitro Antimicrobial Activities of Carbazole and its Derivative From 2014 to 2022. Anti-Infective Agents. 2023 Aug 1;21(4):78-94.

Manchand PS, Coffen DL, Belica PS, Wong F, Wong HS, Berger L. Syntheses of carprofen, a carbazole-based non-steroidal anti-inflammatory agent. Heterocycles. 1994;2(39):833-45.

Kasim SM, Al-Dabbagh BM, Mustafa YF. A review on the biological potentials of carbazole and its derived products. Eurasian ChemCommun. 2022;4(6):495-512.

Caruso A, Ceramella J, Iacopetta D, Saturnino C, Mauro MV, Bruno R, Aquaro S, Sinicropi MS. Carbazole derivatives as antiviral agents: An overview. Molecules. 2019 May 17;24(10):1912.

Bonomo MG, Caruso A, El-Kashef H, Salzano G, Sinicropi MS, Saturnino C. An Update of Carbazole Treatment Strategies for COVID-19 Infection. Applied Sciences. 2023 Jan 24;13(3):1522.

Elitok B, Elitok ÖM. Clinical efficacy of carprofen as an adjunct to the antibacterial treatment of bovine respiratory disease. Journal of veterinary pharmacology and therapeutics. 2004 Oct;27(5):317-20.

Lockwood PW, Johnson JC, Katz TL. Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease. Veterinary record. 2003 Mar;152(13):392-4.

Tolba MS, Hamed MM, Sayed M, Kamal El-Dean AM, Abdel-Mohsen SA, Ibrahim OA, Elgaher WA, Hirsch AK, Saddik AA. Design, synthesis, antimicrobial activity, and molecular docking of some new diclofenac derivatives. Polycyclic Aromatic Compounds. 2023 Jul 3;43(6):5437-52.

Vlad IM, Nuță DC, Căproiu MT, Dumitrașcu F, Kapronczai E, Mük GR, Avram S, Niculescu AG, Zarafu I, Ciorobescu VA, Brezeanu AM. Synthesis and Characterization of New N-acyl Hydrazone Derivatives of Carprofen as Potential Tuberculostatic Agents. Antibiotics. 2024 Feb 23;13(3):212.

Maitra A, Bates S, Shaik M, Evangelopoulos D, Abubakar I, McHugh TD, Lipman M, Bhakta S. Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs. British medical bulletin. 2016 Jun;118(1):138.

Yin Z, Wang Y, Whittell LR, Jergic S, Liu M, Harry E, Dixon NE, Kelso MJ, Beck JL, Oakley AJ. DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs. Chemistry & biology. 2014 Apr 24;21(4):481-7

Brochmann RP, Helmfrid A, Jana B, Magnowska Z, Guardabassi L. Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71. BMC Veterinary Research. 2016 Dec;12(1):1-8.

Pattanashetty SH, Hosamani KM, Satapute P, Joshi SD, Obelannavar K. Discovery of new drugs and computational studies of coumarin-carprofen scaffolds as a novel class of anti-tubercular, anti-inflammatory and anti-bacterial agents. Eur. J. Pharm. Med. Res. 2017;4:486-98.

Pattanashetty SH, Hosamani KM, Shettar AK, Mohammed Shafeeulla R. Design, synthesis and computational studies of novel carbazole n‐phenylacetamide hybrids as potent antibacterial, anti‐inflammatory, and antioxidant agents. Journal of Heterocyclic Chemistry. 2018 Jul;55(7):1765-74.

Luthra PM, Kumar N. Progress and development of C-3, C-6, and N-9 positions substituted carbazole integrated molecular hybrid molecules as potential anticancer agents. Mini Reviews in Medicinal Chemistry. 2021 Nov 1;21(19):2929-56.

Bordei AT, Nuță DC, Musat GC, Missir AV, CaproiuMT, Dumitrascu F, Zarafu I, Ionita P, Daniela C, Badiceanu CL, Ozon EA. Microwave assisted synthesis and spectroscopic characterization of some novel Schiff bases of carprofen hydrazide. Farmacia. 2019;67:955-62.

Popiołek Ł. Hydrazide–hydrazones as potential antimicrobial agents: overview of the literature since 2010. Medicinal Chemistry Research. 2017 Feb;26:287-301.

BordeiTelehoiu AT, Nuță DC, Căproiu MT, Dumitrascu F, Zarafu I, Ioniță P, Bădiceanu CD, Avram S, Chifiriuc MC, Bleotu C, Limban C. Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1, 3, 4-Oxadiazole Scaffolds. Molecules. 2020 Jan 9;25(2):266.

Desai NC, Dodiya AM, Rajpara KM, Rupala YM. Synthesis and antimicrobial screening of 1, 3, 4-oxadiazole and clubbed thiophene derivatives. Journal of Saudi Chemical Society. 2014 Jul 1;18(3):255-61.

Wani MY, Ahmad A, Shiekh RA, Al-Ghamdi KJ, Sobral AJ. Imidazole clubbed 1, 3, 4-oxadiazole derivatives as potential antifungal agents. Bioorganic & medicinal chemistry. 2015 Aug 1;23(15):4172-80.

Maitra A, Evangelopoulos D, Chrzastek A, Martin LT, Hanrath A, Chapman E, Hailes HC, Lipman M, McHugh TD, Waddell SJ, Bhakta S. Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis. Journal of Antimicrobial Chemotherapy. 2020 Nov;75(11):3194-201.

Dumitrascu F, Udrea AM, Caira MR, Nuta DC, Limban C, Chifiriuc MC, Popa M, Bleotu C, Hanganu A, Dumitrescu D, Avram S. In Silico and Experimental Investigation of the Biological Potential of Some Recently Developed Carprofen Derivatives. Molecules. 2022 Apr 23;27(9):2722.

Coandă M, Limban C, Nuță DC. Small Schiff Base Molecules—A Possible Strategy to Combat Biofilm-Related Infections. Antibiotics. 2024 Jan 12;13(1):75

Dumitrascu F, Caira MR, Avram S, Buiu C, Udrea AM, Vlad IM, Zarafu I, Ioniță P, Nuță DC, Popa M, Chifiriuc MC. Repurposing anti-inflammatory drugs for fighting planktonic and biofilm growth. New carbazole derivatives based on the NSAID carprofen: synthesis, in silico and in vitro bioevaluation. Frontiers in Cellular and Infection Microbiology. 2023;13.

Published

2024-10-15

How to Cite

Nitin Kumar, & Pallavi Manish Lavhale. (2024). NSAID Carprofen Structure-based Derivatives as potential antibacterial agents. Asian Journal of Pharmaceutical Research and Development, 12(5), 52–58. https://doi.org/10.22270/ajprd.v12i5.1478